Brief: CRISPR Therapeutics Announces Chief Financial Officer Transition
Mon 22:56
BRIEF-CRISPR Therapeutics Announces Chief Financial Officer Transition Oct 19 (Reuters) - CRISPR Therapeutics AG CRSP.BN:
CRISPR THERAPEUTICS ANNOUNCES CHIEF FINANCIAL OFFICER TRANSITION
CRISPR THERAPEUTICS AG - RAJU PRASAD STEPS DOWN AS CFO; APPOINTS A.J. SILVER AS CFO EFFECTIVE TODAY
Source text: ID:nGNX6G5BtB
Further company coverage: CRSP.BN
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Crispr Therapeutics AG
See all newsBrief: CRISPR Therapeutics Announces Chief Financial Officer Transition
Swiss stocks - Factors to watch on August 4
Switzerland's CRISPR Therapeutics Q2 CASGEVY revenue jumps 151%, net loss narrows on FDA approval for expansion
Swiss stocks - Factors to watch on August 3
Gene-editing firm CRISPR steadies after boosted $550 mln convertible debt deal